Bharat Review
- All
- News
- Videos
-
Applications Invited For Viksit Bharat Fellowship, Stipends Up To Rs 2 Lakh, Check Details
- Friday September 20, 2024
- Education | Edited by Rahul Kumar
Viksit Bharat Fellowship: The selection will follow a rigorous two-step review process conducted by a panel of distinguished leaders and experts from various fields.
- www.ndtv.com/education
-
X User's Review Of Vande Bharat Express Goes Viral, Clocks Over A Million Views
- Wednesday May 1, 2024
- Toshita Sahni
A person from Kolkata shared a thread of posts about her experience aboard a Vande Bharat Express train. Find out what she had to say about the food.
- food.ndtv.com
-
India vs England: Animated Jasprit Bumrah Loses Cool, Fumes At KS Bharat Over Poor DRS Call. Watch
- Saturday January 27, 2024
- NDTV Sports Desk
Jasprit Bumrah was left fuming after KS Bharat's advice against going for a review cost him a wicket. But, the India pacer redeemed himself in the next over.
- sports.ndtv.com
-
Ahead Of Bharat Jodo Yatra's Jammu And Kashmir Leg, Security In This District Reviewed
- Sunday December 11, 2022
- India News | Press Trust of India
As the Rahul Gandhi-led Bharat Jodo Yatra is scheduled to reach Jammu and Kashmir next month, a senior police officer on Sunday reviewed the overall security situation in Kathua the gateway district to the Union Territory bordering Punjab.
- www.ndtv.com
-
India’s Crypto Tax Regime Draws Criticism from Bharat Web3 Association, Details Here
- Monday December 5, 2022
- Written by Radhika Parashar, Edited by Siddharth Suvarna
The Bharat Web3 Association (BWA) has reportedly met with senior officials from India’s finance ministry to review and voice concerns about India’s crypto-related policies and judgement. The BWA, comprised of members from Indian crypto players like WaxirX and CoinSwitch Kuber, is looking to participate actively in helping India formulate adequa...
- www.gadgets360.com
-
Review Of Covaxin Shot Underway, May Get Recommendation In 24 Hours: WHO Official
- Tuesday October 26, 2021
- India News | Reuters
A World Health Organization technical advisory group was reviewing data on Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
- www.ndtv.com
-
After Call To Cut Covishield Dose Gap, Government's Clarification
- Thursday August 26, 2021
- India News | NDTV News Desk
There is no plan to reduce the 84-day dose gap for Covishield, top government expert NK Arora said today as reports said the interval between two shots will be reviewed for the third time this year following a recommendation by health experts.
- www.ndtv.com
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
- Tuesday July 20, 2021
- India News | Asian News International
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
- www.ndtv.com
-
Covaxin To Get WHO Approval "At The Earliest", Says Bharat Biotech
- Monday July 12, 2021
- India News | Asian News International
With a review process of Covaxin, the indigenous vaccine against COVID-19, commencing at the World Health Organisation, the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing from the global body at the earliest
- www.ndtv.com
-
Covaxin "Effectively Neutralises" UK Covid Strain, Claims Bharat Biotech
- Wednesday January 27, 2021
- India News | Reported by Rishika Baruah, Edited by Anindita Sanyal
Bharat Biotech said today that its coronavirus vaccine Covaxin has been found effective against the UK variant of the virus, which is considered 70 per cent more infectious than the Wuhan variety and is more lethal. In a tweet today, Bharat Biotech said "Covaxin effectively neutralises UK variants of SARS-CoV-2 reducing the possibility of mutant vi...
- www.ndtv.com
-
Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing
- Friday January 22, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy
Covaxin, India's first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.
- www.ndtv.com
-
India A Step Closer To Covid Vaccine, Drug Regulator Approval Awaited: 10 Facts
- Sunday January 3, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Swati Bhasin
India has moved a step closer to getting a coronavirus vaccine as two candidates - Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield - have been recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days. The country has been preparing for t...
- www.ndtv.com
-
Expert Panel Reviews Bharat Biotech Vaccine For Emergency Use
- Saturday January 2, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Nandini Gupta
A panel of government experts met today to review Bharat Biotech's application for emergency use of its vaccine Covaxin - India's first COVID-19 jab developed indigenously in collaboration with the country's top medical research body ICMR.
- www.ndtv.com
-
Covid Vaccines Being "Analysed Aggressively", Says Minister Amid Key Meet
- Friday January 1, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being taken up once again for consideration by a government-appointed panel of experts today.
- www.ndtv.com
-
Applications Invited For Viksit Bharat Fellowship, Stipends Up To Rs 2 Lakh, Check Details
- Friday September 20, 2024
- Education | Edited by Rahul Kumar
Viksit Bharat Fellowship: The selection will follow a rigorous two-step review process conducted by a panel of distinguished leaders and experts from various fields.
- www.ndtv.com/education
-
X User's Review Of Vande Bharat Express Goes Viral, Clocks Over A Million Views
- Wednesday May 1, 2024
- Toshita Sahni
A person from Kolkata shared a thread of posts about her experience aboard a Vande Bharat Express train. Find out what she had to say about the food.
- food.ndtv.com
-
India vs England: Animated Jasprit Bumrah Loses Cool, Fumes At KS Bharat Over Poor DRS Call. Watch
- Saturday January 27, 2024
- NDTV Sports Desk
Jasprit Bumrah was left fuming after KS Bharat's advice against going for a review cost him a wicket. But, the India pacer redeemed himself in the next over.
- sports.ndtv.com
-
Ahead Of Bharat Jodo Yatra's Jammu And Kashmir Leg, Security In This District Reviewed
- Sunday December 11, 2022
- India News | Press Trust of India
As the Rahul Gandhi-led Bharat Jodo Yatra is scheduled to reach Jammu and Kashmir next month, a senior police officer on Sunday reviewed the overall security situation in Kathua the gateway district to the Union Territory bordering Punjab.
- www.ndtv.com
-
India’s Crypto Tax Regime Draws Criticism from Bharat Web3 Association, Details Here
- Monday December 5, 2022
- Written by Radhika Parashar, Edited by Siddharth Suvarna
The Bharat Web3 Association (BWA) has reportedly met with senior officials from India’s finance ministry to review and voice concerns about India’s crypto-related policies and judgement. The BWA, comprised of members from Indian crypto players like WaxirX and CoinSwitch Kuber, is looking to participate actively in helping India formulate adequa...
- www.gadgets360.com
-
Review Of Covaxin Shot Underway, May Get Recommendation In 24 Hours: WHO Official
- Tuesday October 26, 2021
- India News | Reuters
A World Health Organization technical advisory group was reviewing data on Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
- www.ndtv.com
-
After Call To Cut Covishield Dose Gap, Government's Clarification
- Thursday August 26, 2021
- India News | NDTV News Desk
There is no plan to reduce the 84-day dose gap for Covishield, top government expert NK Arora said today as reports said the interval between two shots will be reviewed for the third time this year following a recommendation by health experts.
- www.ndtv.com
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
- Tuesday July 20, 2021
- India News | Asian News International
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
- www.ndtv.com
-
Covaxin To Get WHO Approval "At The Earliest", Says Bharat Biotech
- Monday July 12, 2021
- India News | Asian News International
With a review process of Covaxin, the indigenous vaccine against COVID-19, commencing at the World Health Organisation, the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing from the global body at the earliest
- www.ndtv.com
-
Covaxin "Effectively Neutralises" UK Covid Strain, Claims Bharat Biotech
- Wednesday January 27, 2021
- India News | Reported by Rishika Baruah, Edited by Anindita Sanyal
Bharat Biotech said today that its coronavirus vaccine Covaxin has been found effective against the UK variant of the virus, which is considered 70 per cent more infectious than the Wuhan variety and is more lethal. In a tweet today, Bharat Biotech said "Covaxin effectively neutralises UK variants of SARS-CoV-2 reducing the possibility of mutant vi...
- www.ndtv.com
-
Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing
- Friday January 22, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy
Covaxin, India's first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.
- www.ndtv.com
-
India A Step Closer To Covid Vaccine, Drug Regulator Approval Awaited: 10 Facts
- Sunday January 3, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Swati Bhasin
India has moved a step closer to getting a coronavirus vaccine as two candidates - Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield - have been recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days. The country has been preparing for t...
- www.ndtv.com
-
Expert Panel Reviews Bharat Biotech Vaccine For Emergency Use
- Saturday January 2, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Nandini Gupta
A panel of government experts met today to review Bharat Biotech's application for emergency use of its vaccine Covaxin - India's first COVID-19 jab developed indigenously in collaboration with the country's top medical research body ICMR.
- www.ndtv.com
-
Covid Vaccines Being "Analysed Aggressively", Says Minister Amid Key Meet
- Friday January 1, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being taken up once again for consideration by a government-appointed panel of experts today.
- www.ndtv.com